Electroporation-based technologies for medicine: principles, applications, and challenges.

When high-amplitude, short-duration pulsed electric fields are applied to cells and tissues, the permeability of the cell membranes and tissue is increased. This increase in permeability is currently explained by the temporary appearance of aqueous pores within the cell membrane, a phenomenon termed electroporation. During the past four decades, advances in fundamental and experimental electroporation research have allowed for the translation of electroporation-based technologies to the clinic. In this review, we describe the theory and current applications of electroporation in medicine and then discuss current challenges in electroporation research and barriers to a more extensive spread of these clinical applications.

[1]  R. Pal,et al.  Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. , 2008, Vaccine.

[2]  Damijan Miklavcic,et al.  Kinetics of transmembrane transport of small molecules into electropermeabilized cells. , 2008, Biophysical journal.

[3]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.

[4]  Tanja Cufer,et al.  Electrochemotherapy of chest wall breast cancer recurrence. , 2012, Cancer treatment reviews.

[5]  Stephen T Kee,et al.  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. , 2010, Radiology.

[6]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  Damijan Miklavcic,et al.  The influence of skeletal muscle anisotropy on electroporation: in vivo study and numerical modeling , 2010, Medical & Biological Engineering & Computing.

[8]  Jens Ricke,et al.  1408 IRREVERSIBLE ELECTROPORATION FOR THE TREATMENT OF EARLY-STAGE HEPATOCELLULAR CARCINOMA. A PROSPECTIVE MULTICENTER PHASE 2 STUDY ASSESSING SAFETY AND EFFICACY , 2012 .

[9]  Paulo A. Garcia,et al.  Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion , 2010, Biomedical engineering online.

[10]  I. Sugár.  A theory of the electric field-induced phase transition of phospholipid bilayers. , 1979, Biochimica et biophysica acta.

[11]  G. Botti,et al.  Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma , 2012, Journal of Translational Medicine.

[12]  Véronique Préat,et al.  Skin electroporation for transdermal and topical delivery. , 2004, Advanced drug delivery reviews.

[13]  B. Rubinsky,et al.  Tissue Ablation with Irreversible Electroporation , 2005, Annals of Biomedical Engineering.

[14]  M. Samman,et al.  Irreversible Electroporation: Hype or Hope? , 2013, CardioVascular and Interventional Radiology.

[15]  M. Golzio,et al.  Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases. , 2012, Equine veterinary journal.

[16]  L. Prosen,et al.  Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity , 2012, Radiology and oncology.

[17]  D. Miklavčič,et al.  In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[18]  J. Saunders,et al.  Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. , 2009, Vaccine.

[19]  V. Sondak,et al.  Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Mir,et al.  Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. , 1992, European cytokine network.

[21]  Antoni Ivorra,et al.  Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. , 2012, Cancer letters.

[22]  Boris Rubinsky,et al.  Cancer Cells Ablation with Irreversible Electroporation , 2005, Technology in cancer research & treatment.

[23]  S. Szala,et al.  Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread , 2002, Cancer Gene Therapy.

[24]  S. Orlowski,et al.  First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. , 1997, British Journal of Cancer.

[25]  Boris Rubinsky,et al.  In vivo imaging of irreversible electroporation by means of electrical impedance tomography , 2009, Physics in medicine and biology.

[26]  D. Miklavčič,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0222 , 2022 .

[27]  A. Golberg,et al.  Galvanic apparent internal impedance: an intrinsic tissue property. , 2009, Biochemical and biophysical research communications.

[28]  Tadej Kotnik,et al.  Sensitivity of transmembrane voltage induced by applied electric fields—A theoretical analysis , 1997 .

[29]  L. Cruzeiro-Hansson,et al.  Passive ion permeability of lipid membranes modelled via lipid-domain interfacial area. , 1988, Biochimica et biophysica acta.

[30]  A. Stringaro,et al.  Ultrastructural modifications of cell membranes induced by “electroporation” on melanoma xenografts , 2007, Microscopy research and technique.

[31]  K. Schoenbach,et al.  Intracellular effect of ultrashort electrical pulses , 2001, Bioelectromagnetics.

[32]  M. Čemažar,et al.  Electrochemotherapy compared to surgery for treatment of canine mast cell tumours. , 2009, In vivo.

[33]  Boris Rubinsky,et al.  MRI Study on Reversible and Irreversible Electroporation Induced Blood Brain Barrier Disruption , 2012, PloS one.

[34]  L. Mir,et al.  [Electrochemotherapy, a new antitumor treatment: first clinical trial]. , 1991, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[35]  S. Szala,et al.  Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours. , 2005, Acta biochimica Polonica.

[36]  Boris Rubinsky,et al.  A statistical model for multidimensional irreversible electroporation cell death in tissue , 2010, Biomedical engineering online.

[37]  Damijan Miklavčič,et al.  A Numerical Model of Skin Electropermeabilization Based on In Vivo Experiments , 2007, Annals of Biomedical Engineering.

[38]  Laurence Zitvogel,et al.  Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses , 2008, Cancer Immunology, Immunotherapy.

[39]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[40]  Boris Rubinsky,et al.  The Effect of Irreversible Electroporation on Blood Vessels , 2007, Technology in cancer research & treatment.

[41]  Damijan Miklavcic,et al.  A Numerical Model of Permeabilized Skin With Local Transport Regions , 2008, IEEE Transactions on Biomedical Engineering.

[42]  Damijan Miklavcic,et al.  Ex Vivo and In Silico Feasibility Study of Monitoring Electric Field Distribution in Tissue during Electroporation Based Treatments , 2012, PloS one.

[43]  Damijan Miklavcic,et al.  Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors , 2012, Medical and Biological Engineering and Computing.

[44]  J. Buckholz,et al.  Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs , 2010, Cancer Gene Therapy.

[45]  Richard Heller,et al.  Electroporation gene therapy preclinical and clinical trials for melanoma. , 2010, Current gene therapy.

[46]  B Rubinsky,et al.  Irreversible electroporation on the small intestine , 2012, British Journal of Cancer.

[47]  Luigi Corti,et al.  The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study , 2012, Breast Cancer Research and Treatment.

[48]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[49]  S. Hui,et al.  Painless skin electroporation as a novel way for insulin delivery. , 2011, Diabetes technology & therapeutics.

[50]  Yong Huang,et al.  Microfabricated electroporation chip for single cell membrane permeabilization , 2001 .

[51]  Vic Velanovich,et al.  Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. , 2012, Journal of the American College of Surgeons.

[52]  Tadej Kotnik,et al.  Lightning-triggered electroporation and electrofusion as possible contributors to natural horizontal gene transfer. , 2012, Physics of life reviews.

[53]  D Miklavcic,et al.  Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. , 2008, Human gene therapy.

[54]  M. Rols,et al.  In vivo electrically mediated protein and gene transfer in murine melanoma , 1998, Nature Biotechnology.

[55]  T. L. Ellis,et al.  Non-Thermal Irreversible Electroporation (N-TIRE) and Adjuvant Fractionated Radiotherapeutic Multimodal Therapy for Intracranial Malignant Glioma in a Canine Patient , 2011, Technology in cancer research & treatment.

[56]  Richard Heller,et al.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  Véronique Préat,et al.  Topical Gene Transfer into Rat Skin Using Electroporation , 2004, Pharmaceutical Research.

[58]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[59]  Damijan Miklavcic,et al.  Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation , 2012, Physics in medicine and biology.

[60]  M. Čemažar,et al.  Multiple Delivery of siRNA against Endoglin into Murine Mammary Adenocarcinoma Prevents Angiogenesis and Delays Tumor Growth , 2013, PloS one.

[61]  Rafael V. Davalos,et al.  Intracranial Nonthermal Irreversible Electroporation: In Vivo Analysis , 2010, The Journal of Membrane Biology.

[62]  Damijan Miklavčič,et al.  Planning of Electroporation-Based Treatments Using Web-Based Treatment-Planning Software , 2013, The Journal of Membrane Biology.

[63]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[64]  S. Bagla,et al.  Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. , 2012, Journal of vascular and interventional radiology : JVIR.

[65]  J. Gehl,et al.  Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. , 2013, Human gene therapy. Clinical development.

[66]  Antonella Vecchiato,et al.  Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients , 2008, Annals of Surgical Oncology.

[67]  Damijan Miklavcic,et al.  Real time electroporation control for accurate and safe in vivo non-viral gene therapy. , 2007, Bioelectrochemistry.

[68]  D. Miklavcic,et al.  Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. , 1998, British Journal of Cancer.

[69]  D. H. Michael,et al.  Electrohydrodynamic instability in plane layers of fluid , 1970, Journal of Fluid Mechanics.

[70]  V. Préat,et al.  Mechanisms of a Phosphorothioate Oligonucleotide Delivery by Skin Electroporation , 1998 .

[71]  M Cemazar,et al.  Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. , 2001, Anticancer research.

[72]  Boris Rubinsky,et al.  In vivo results of a new focal tissue ablation technique: irreversible electroporation , 2006, IEEE Transactions on Biomedical Engineering.

[73]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.

[74]  D Miklavcic,et al.  Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma , 2008, British Journal of Cancer.

[75]  R. Stämpfli,et al.  Membrane potential of a ranvier node measured after electrical destruction of its membrane , 1957, Experientia.

[76]  Boris Rubinsky,et al.  Methods of optimization of electrical impedance tomography for imaging tissue electroporation , 2007, Physiological measurement.

[77]  Damijan Miklavcic,et al.  Theoretical evaluation of voltage inducement on internal membranes of biological cells exposed to electric fields. , 2006, Biophysical journal.

[78]  Hong Qian,et al.  Statistics and Related Topics in Single-Molecule Biophysics. , 2014, Annual review of statistics and its application.

[79]  Lucie Delemotte,et al.  Molecular Dynamics Simulations of Lipid Membrane Electroporation , 2012, The Journal of Membrane Biology.

[80]  N. Sardesai,et al.  Electroporation delivery of DNA vaccines: prospects for success. , 2011, Current opinion in immunology.

[81]  Rafael V. Davalos,et al.  Successful treatment of a large soft tissue sarcoma with irreversible electroporation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  M. Čemažar,et al.  Cancer electrogene therapy with interleukin-12. , 2010, Current gene therapy.

[83]  Markus Porsch,et al.  Urinary Tract Effects After Multifocal Nonthermal Irreversible Electroporation of the Kidney: Acute and Chronic Monitoring by Magnetic Resonance Imaging, Intravenous Urography and Urinary Cytology , 2012, CardioVascular and Interventional Radiology.

[84]  M. Golzio,et al.  Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors. , 2012, Human gene therapy.

[85]  Martin L. Yarmush,et al.  Nonthermal Irreversible Electroporation: Fundamentals, Applications, and Challenges , 2013, IEEE Transactions on Biomedical Engineering.

[86]  L. Mir,et al.  Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumor growth, and antimetastatic effect. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[87]  S W Hui,et al.  Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. , 2006, Vaccine.

[88]  B. Rubinsky,et al.  In vivo non-thermal irreversible electroporation impact on rat liver galvanic apparent internal resistance , 2011, Physics in medicine and biology.

[89]  L. Widén,et al.  Anode break excitation in desheathed frog nerve , 1956, The Journal of physiology.

[90]  T. Jarm,et al.  Electrochemotherapy , 2011, Technology in cancer research & treatment.

[91]  J. Crowley,et al.  Electrical breakdown of bimolecular lipid membranes as an electromechanical instability. , 1973, Biophysical journal.

[92]  A. Luxembourg,et al.  Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. , 2010, Vaccine.

[93]  Damijan Miklavcic,et al.  Second-order model of membrane electric field induced by alternating external electric fields , 2000, IEEE Transactions on Biomedical Engineering.

[94]  Thomas L Ellis,et al.  Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. , 2011, Journal of neurosurgery.

[95]  Damijan Miklavcic,et al.  Magnetic Resonance Electrical Impedance Tomography for Monitoring Electric Field Distribution During Tissue Electroporation , 2011, IEEE Transactions on Medical Imaging.

[96]  M. Čemažar,et al.  Differential Mechanisms Associated with Vascular Disrupting Action of Electrochemotherapy: Intravital Microscopy on the Level of Single Normal and Tumor Blood Vessels , 2013, PloS one.

[97]  A. Sanfeld,et al.  A Viscoelastic Approach to the Hydrodynamic Stability of Membranes , 1982 .

[98]  J. Buckholz,et al.  Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs , 2010, Cancer Gene Therapy.

[99]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[100]  Shulin Li,et al.  Regression of High-Grade Malignancy in Mice by Bleomycin and Interleukin-12 Electrochemogenetherapy , 2006, Clinical Cancer Research.

[101]  Damijan Miklavcic,et al.  Tumor size and effectiveness of electrochemotherapy , 2013, Radiology and oncology.

[102]  R. E. Neal,et al.  Spectrum of imaging and characteristics for liver tumors treated with irreversible electroporation , 2012 .

[103]  D Miklavcic,et al.  Electrochemotherapy in treatment of tumours. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[104]  M. Rols,et al.  Equine Cutaneous Tumors Treatment by Electro-chemo-immuno-geno-therapy , 2007 .

[105]  M. Jaroszeski,et al.  In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity , 2000, Melanoma research.

[106]  J. Gehl,et al.  Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.

[107]  Véronique Préat,et al.  Transdermal Delivery of Fentanyl by Electroporation I. Influence of Electrical Factors , 1996, Pharmaceutical Research.

[108]  J. Weaver,et al.  Theory of electroporation of planar bilayer membranes: predictions of the aqueous area, change in capacitance, and pore-pore separation. , 1994, Biophysical journal.

[109]  Helen Kavnoudias,et al.  Investigation of the safety of irreversible electroporation in humans. , 2011, Journal of vascular and interventional radiology : JVIR.

[110]  D. Miklavčič,et al.  Cell membrane electroporation- Part 1: The phenomenon , 2012, IEEE Electrical Insulation Magazine.

[111]  Jonathan D. Stallings,et al.  Improved Local and Systemic Anti-Tumor Efficacy for Irreversible Electroporation in Immunocompetent versus Immunodeficient Mice , 2013, PloS one.

[112]  G. Saulis,et al.  Kinetics of pore resealing in cell membranes after electroporation , 1991 .

[113]  N. Pavselj,et al.  DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[114]  Helen Kavnoudias,et al.  Irreversible Electroporation: A New Challenge in “Out of Operating Theater” Anesthesia , 2010, Anesthesia and analgesia.

[115]  L M Loew,et al.  Voltage-sensitive dyes: measurement of membrane potentials induced by DC and AC electric fields. , 1992, Bioelectromagnetics.

[116]  G. Citro,et al.  Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. , 2011, Journal of veterinary internal medicine.

[117]  L. Mir,et al.  Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice , 1997 .

[118]  Wenjun Ying,et al.  Hybrid Finite Element Method for Describing the Electrical Response of Biological Cells to Applied Fields , 2007, IEEE Transactions on Biomedical Engineering.

[119]  A. Testori,et al.  Local and intralesional therapy of in‐transit melanoma metastases , 2011, Journal of surgical oncology.

[120]  L. Mir,et al.  Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.

[121]  D. Dean,et al.  Electrotransfer as a non viral method of gene delivery. , 2007, Current gene therapy.

[122]  T. Wu,et al.  Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection. , 2011, Vaccine.

[123]  P. Capasso,et al.  Electrochemotherapy for Non-Melanoma Head and Neck Cancers: Clinical Outcomes in 25 Patients , 2012, Annals of surgery.

[124]  D Miklavcic,et al.  Electrochemotherapy in veterinary oncology. , 2008, Journal of Veterinary Internal Medicine.

[125]  Damijan Miklavčič,et al.  Measuring the Induced Membrane Voltage with Di-8-ANEPPS , 2009, Journal of visualized experiments : JoVE.

[126]  J. Gehl,et al.  Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs , 1998, Anti-cancer drugs.

[127]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[128]  Damijan Miklavčič,et al.  Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study , 2006 .

[129]  G. A. Hofmann,et al.  Medical applications of electroporation , 2000 .

[130]  Damijan Miklavčič,et al.  Active enhancement methods for intra- and transdermal drug delivery: a review. , 2013 .

[131]  T. Geng,et al.  Flow-through electroporation based on constant voltage for large-volume transfection of cells. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[132]  M. Rols,et al.  Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells , 2011, Proceedings of the National Academy of Sciences.

[133]  C. Collins,et al.  Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes , 2006 .

[134]  A. Testori,et al.  Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach , 2010, Dermatologic therapy.

[135]  Jon F Edd,et al.  Mathematical Modeling of Irreversible Electroporation for Treatment Planning , 2007, Technology in cancer research & treatment.

[136]  IL-12 based gene therapy in veterinary medicine , 2012, Journal of Translational Medicine.

[137]  Shengnian Wang,et al.  Micro-/nanofluidics based cell electroporation. , 2013, Biomicrofluidics.

[138]  S. van Drunen Littel-van den Hurk,et al.  Electroporation for DNA immunization: clinical application , 2010, Expert review of vaccines.

[139]  J. Gehl,et al.  Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial , 2012, Acta oncologica.

[140]  Damijan Miklavcic,et al.  A Time-Dependent Numerical Model of Transmembrane Voltage Inducement and Electroporation of Irregularly Shaped Cells , 2009, IEEE Transactions on Biomedical Engineering.

[141]  M. Golzio,et al.  Intravital microscopy at the single vessel level brings new insights of vascular modification mechanisms induced by electropermeabilization. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[142]  Yuman Fong,et al.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation. , 2012, Journal of the American College of Surgeons.

[143]  J. Teissié,et al.  Muscle gene electrotransfer is increased by the antioxidant tempol in mice , 2011, Gene Therapy.

[144]  G. Pucihar,et al.  Numerical Determination of Transmembrane Voltage Induced on Irregularly Shaped Cells , 2006, Annals of Biomedical Engineering.

[145]  Boris Rubinsky,et al.  In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome , 2009, Physics in medicine and biology.

[146]  J Teissié,et al.  Electrochemotherapy of horses. A preliminary clinical report. , 2002, Bioelectrochemistry.

[147]  James C. Weaver,et al.  Feasibility of an Electrode-Reservoir Device for Transdermal Drug Delivery by Noninvasive Skin Electroporation , 2007, IEEE Transactions on Biomedical Engineering.

[148]  L. Prosen,et al.  Biological Properties of Melanoma and Endothelial Cells after Plasmid AMEP Gene Electrotransfer Depend on Integrin Quantity on Cells , 2013, The Journal of Membrane Biology.

[149]  D. Miklavčič,et al.  Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. , 1997, Cancer letters.

[150]  Boris Rubinsky,et al.  Variable electric fields for high throughput electroporation protocol design in curvilinear coordinates. , 2012, Biotechnology and bioengineering.

[151]  M. Rols,et al.  Direct visualization at the single-cell level of electrically mediated gene delivery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[152]  T. Tsong,et al.  Electroporation of cell membranes. , 1991, Biophysical journal.

[153]  M. M. Diogo,et al.  Plasmid DNA size does affect nonviral gene delivery efficiency in stem cells. , 2012, Cellular reprogramming.

[154]  B. Levine,et al.  Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. , 2010, Cancer research.

[155]  S. Sukharev,et al.  In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. , 1991, Biochimica et biophysica acta.

[156]  Martin L Yarmush,et al.  Regeneration and control of human fibroblast cell density by intermittently delivered pulsed electric fields , 2013, Biotechnology and bioengineering.

[157]  Jacob Sosna,et al.  US findings after irreversible electroporation ablation: radiologic-pathologic correlation. , 2012, Radiology.

[158]  Damijan Miklavčič,et al.  Time course of transmembrane voltage induced by time-varying electric fields—a method for theoretical analysis and its application , 1998 .

[159]  Yang Guo,et al.  Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. , 2010, Cancer research.

[160]  J. Weaver,et al.  Theory of electroporation: A review , 1996 .

[161]  Susana Marcos,et al.  From unseen to seen: tackling the global burden of uncorrected refractive errors. , 2014, Annual review of biomedical engineering.

[162]  H. Itoh,et al.  Time courses of cell electroporation as revealed by submicrosecond imaging of transmembrane potential. , 1993, Biophysical journal.

[163]  Boris Rubinsky,et al.  Irreversible Electroporation: First Patient Experience Focal Therapy of Prostate Cancer , 2010 .

[164]  Martin L Yarmush,et al.  Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration. , 2013, Technology.

[165]  Damijan Miklavčič,et al.  Induced Transmembrane Voltage and Its Correlation with Electroporation-Mediated Molecular Transport , 2010, The Journal of Membrane Biology.

[166]  L. Mir,et al.  A Study of the Immunological Response to Tumor Ablation with Irreversible Electroporation , 2007, Technology in cancer research & treatment.

[167]  Boris Rubinsky,et al.  Irreversible Electroporation: A New Ablation Modality — Clinical Implications , 2007, Technology in cancer research & treatment.

[168]  M. Čemažar,et al.  Electrotransfer of therapeutic molecules into tissues. , 2007, Current opinion in molecular therapeutics.

[169]  J. Gimsa,et al.  Analytical description of the transmembrane voltage induced on arbitrarily oriented ellipsoidal and cylindrical cells. , 2001, Biophysical journal.

[170]  Damijan Miklavčič,et al.  Network for Development of Electroporation-Based Technologies and Treatments: COST TD1104 , 2012, The Journal of Membrane Biology.

[171]  Richard Heller,et al.  In vivo electroporation for gene therapy. , 2006, Human gene therapy.

[172]  J. Tao,et al.  Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach , 2005, The British journal of dermatology.

[173]  Boris Rubinsky,et al.  Irreversible Electroporation: Implications for Prostate Ablation , 2007, Technology in cancer research & treatment.

[174]  Damijan Miklavcic,et al.  Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases , 2010, Expert review of anticancer therapy.

[175]  A. Leroy-Willig,et al.  In vivo MRI Follow-up of Murine Tumors Treated by Electrochemotherapy and other Electroporation-based Treatments , 2012, Technology in cancer research & treatment.

[176]  Jens Ricke,et al.  Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study , 2011, CardioVascular and Interventional Radiology.

[177]  D Miklavcic,et al.  Analytical description of transmembrane voltage induced by electric fields on spheroidal cells. , 2000, Biophysical journal.

[178]  M. Okino,et al.  Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. , 1987, Japanese journal of cancer research : Gann.

[179]  Ronak Talati,et al.  Irreversible electroporation of lung neoplasm: A case series , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[180]  Boris Rubinsky,et al.  Towards Electroporation Based Treatment Planning considering Electric Field Induced Muscle Contractions , 2012, Technology in cancer research & treatment.

[181]  Genetic Manipulation of Human Embryonic Stem Cells , 2003 .

[182]  Paulo A. Garcia,et al.  High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction , 2011, Biomedical engineering online.

[183]  M. Akashi,et al.  In vivo induction of cytotoxic T lymphocytes specific for a single epitope introduced into an unrelated molecule. , 1996, Journal of immunological methods.

[184]  R. Heller.  Treatment of cutaneous nodules using electrochemotherapy. , 1995, The Journal of the Florida Medical Association.